SCHEMBL1090475

SCHEMBL1090475

O=S(=O)(c1ccc(Cl)cc1)N1CCC(N2CCCC(Nc3nccc(N4CCCCCC4)n3)C2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.55
▸ CXCR4 P61073 1/20 0.47
▸ MEN1 O00255 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ CCNE1 P24864 1/20 0.44
▸ CDK2 P24941 1/20 0.44
▸ HRH4 Q9H3N8 3/20 0.43
▸ IKBKB O14920 6/20 0.43
▸ KDM4E B2RXH2 4/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ GAA P10253 2/20 0.42
▸ MAPK8 P45983 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ CHUK O15111 1/20 0.41
▸ MAPK9 P45984 1/20 0.41
▸ MAPK10 P53779 1/20 0.41
▸ MAPK11 Q15759 1/20 0.41
▸ MAPK14 Q16539 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090153 0.98 ALDH1A1 (0.55) ALDH1A1CXCR4MEN1MAPK1KMT2A
SCHEMBL1090617 0.96 ALDH1A1 (0.53) ALDH1A1CXCR4MEN1MAPK1KMT2A
SCHEMBL1090292 0.92 CXCR4 (0.47) ALDH1A1CXCR4MEN1MAPK1KMT2A
SCHEMBL1090644 0.91 HRH4 (0.46) ALDH1A1CXCR4MEN1MAPK1KMT2A
SCHEMBL1089014 0.91 ALDH1A1 (0.55) ALDH1A1CXCR4HRH4IKBKBKDM4E
SCHEMBL1090389 0.91 KDM4E (0.54) ALDH1A1CXCR4MEN1KMT2AHRH4
SCHEMBL1090079 0.90 ALDH1A1 (0.55) ALDH1A1CXCR4HRH4IKBKBKDM4E
SCHEMBL1089744 0.89 GAA (0.54) ALDH1A1CXCR4CCNE1CDK2HRH4
SCHEMBL1091184 0.89 ALDH1A1 (0.57) ALDH1A1CXCR4HRH4KDM4EGAA
SCHEMBL1089244 0.89 CCR6 (0.46) ALDH1A1CXCR4CDK2HRH4IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 — — US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 — — US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 — — US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 — — US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885CXCR4 1/4885MEN1 3648/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885CXCR4 1/4885MEN1 3648/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885CXCR4 1/4885MEN1 3648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback